Deposition of α-synuclein (αS) aggregates inside brain cells is a pathological hallmark of
several neurodegenerative diseases, including Parkinson's disease (PD), and dementia …

The aggregation of α-synuclein (αS) in the central nervous system (CNS) is the hallmark of
multiple system atrophy (MSA) and Lewy body diseases including Parkinson's disease (PD) …

Alzheimer's disease (AD) and Parkinson's disease (PD), including dementia with Lewy
bodies (DLB), account for the majority of dementia cases worldwide. Interestingly, a …

Introduction The objective was to study whether α-synuclein oligomers are altered in the
cerebrospinal fluid (CSF) of patients with dementia, including Parkinson disease with …

Aggregated α-synuclein is the major component of Lewy bodies, protein inclusions
observed in the brain in neurodegenerative disorders such as Parkinson's disease and …

Abstract α-Synuclein is the major constituent of Lewy bodies and Lewy neurites in
Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Relatively little is known …

The α-synuclein (αSN) protein is thought to play a central role in the pathogenesis of
neurodegenerative diseases where it aggregates to form intracellular inclusions. We have …

Alzheimer's disease, the most prevalent age-related neurodegenerative disease, is
characterized by the presence of extracellular senile plaques composed of amyloid-beta …

A growing body of evidence suggests that the non-Aβ component of Alzheimer's disease
amyloid precursor protein (NACP) or α-synuclein contributes to the neurodegenerative …

A number of neurodegenerative diseases including Parkinson's disease, dementia with
Lewy bodies (DLB) and multiple system atrophy are characterized by the formation and …